35
|
216
|
8hq7N |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
46
|
213
|
8hrdE |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
47
|
229
|
8hrdD |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
44
|
215
|
8hrdF |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
44
|
230
|
8hrdC |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
27
|
114
|
8q93B |
Crystal structure of the sars-cov-2 rbd with neutralizing-vhhs re30h02 and re21d01 |
32
|
231
|
8hq7H |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
36
|
215
|
8hq7L |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
31
|
195
|
8hq7A |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
31
|
128
|
8q94B |
Crystal structure of the sars-cov-2 ba.2.75 rbd with neutralizing-vhhs re32d03 and ma3b12 |
25
|
116
|
8q7sB |
Crystal structure of the sars-cov-2 rbd (wuhan) with neutralizing vhhs ma6f06 and re21h01 |
29
|
116
|
8q95C |
Crystal structure of the sars-cov-2 ba.1 rbd with neutralizing-vhhs ma16b06 and ma3f05 |
24
|
126
|
8q7sC |
Crystal structure of the sars-cov-2 rbd (wuhan) with neutralizing vhhs ma6f06 and re21h01 |
44
|
184
|
8q95A |
Crystal structure of the sars-cov-2 ba.1 rbd with neutralizing-vhhs ma16b06 and ma3f05 |
26
|
130
|
8q93C |
Crystal structure of the sars-cov-2 rbd with neutralizing-vhhs re30h02 and re21d01 |
40
|
195
|
8hrdA |
Crystal structure of the receptor binding domain of sars-cov-2 delta variant in complex with imcas74 fab and w14 fab |
41
|
225
|
8hq7M |
Cryo-em structure of sars-cov-2 omicron prototype rbd in complex with fab l4.65 and l5.34 |
27
|
127
|
8q94C |
Crystal structure of the sars-cov-2 ba.2.75 rbd with neutralizing-vhhs re32d03 and ma3b12 |
37
|
215
|
6zdgC |
Association of three complexes of largely structurally disordered spike ectodomain with bound ey6a fab |
44
|
214
|
7ps0C |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-24 fabs |
48
|
213
|
7ps1B |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-27 fab |
39
|
194
|
7ps7E |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-40 fab |
27
|
118
|
7spoC |
Crystal structure of the sars-cov-2 receptor binding domain in complex with vnar 3b4 |
24
|
110
|
7sppC |
Crystal structure of the sars-cov-2 receptor binding domain in complex with vnar 2c02 |
41
|
195
|
7sppA |
Crystal structure of the sars-cov-2 receptor binding domain in complex with vnar 2c02 |
36
|
218
|
7wueC |
Crystal structure of sars-cov-2 receptor binding domain in complex with the monoclonal antibody m31a7 |
30
|
126
|
7z1cE |
Nanobody h11-b5 and h11-f2 bound to rbd |
45
|
194
|
7z1eEEE |
Nanobody h11-h4 q98r h100e bound to rbd |
33
|
125
|
7z1bB |
Nanobody h11-a10 and f2 bound to rbd |
46
|
196
|
7z1cA |
Nanobody h11-b5 and h11-f2 bound to rbd |
31
|
128
|
7z1aE |
Nanobody h11 and f2 bound to rbd |
36
|
195
|
7wueA |
Crystal structure of sars-cov-2 receptor binding domain in complex with the monoclonal antibody m31a7 |
44
|
212
|
7wphD |
Sars-cov2 rbd bound to fab06 |
33
|
125
|
7z1cB |
Nanobody h11-b5 and h11-f2 bound to rbd |
46
|
194
|
7tp4Z |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k398.22 |
48
|
231
|
7tp3H |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k288.2 |
48
|
225
|
7tp4H |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k398.22 |
39
|
194
|
7tp3Z |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k288.2 |
49
|
214
|
7tp3L |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k288.2 |
43
|
211
|
7tp4L |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody k398.22 |
21
|
106
|
7theC |
Structure of rbd directed antibody dh1042 in complex with sars-cov-2 spike: local refinement of rbd-fab interface |
21
|
122
|
7theB |
Structure of rbd directed antibody dh1042 in complex with sars-cov-2 spike: local refinement of rbd-fab interface |
40
|
195
|
7theA |
Structure of rbd directed antibody dh1042 in complex with sars-cov-2 spike: local refinement of rbd-fab interface |
26
|
231
|
7tc9H |
Locally refined region of sars-cov-2 spike in complex with antibody a19-46.1 |
43
|
196
|
7q0gE |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-49 and fi-3a fabs |
24
|
216
|
7tc9L |
Locally refined region of sars-cov-2 spike in complex with antibody a19-46.1 |
48
|
218
|
7q0gH |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-49 and fi-3a fabs |
47
|
216
|
7q0gB |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-49 and fi-3a fabs |
51
|
213
|
7ps4C |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-38 |
39
|
228
|
7ps4B |
Crystal structure of the receptor binding domain of sars-cov-2 beta variant spike glycoprotein in complex with beta-38 |